MedPage Today on MSN
Trial casts doubt on antibiotics for refractory low back pain
Now it's up to clinicians to sort out conflicting evidence ...
Pharmaceutical Technology on MSN
Vertanical’s VER-01 gains FDA breakthrough status for low back pain
VER-01 offers an investigational approach distinct from traditional treatment paradigms.
We didn’t evolve for this level of inactivity.” If you sit a lot, a few small routine tweaks can make a big difference.
Most nonsurgical and noninterventional treatments for low back pain failed to outperform placebo in a new systematic review and meta-analysis, with just 10% showing only modest pain relief.
VERTANICAL today announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to VER-01, the company's first-in-class non-opioid investigational treatment for ...
Chronic low back pain is one of the most prevalent and disabling medical conditions worldwide. Chronic low back pain can interfere with work, family life, and overall wellbeing. Despite advances in ...
Chronic back pain is the most common type of pain, affecting around 16 million American adults — and now a new study has revealed some discouraging findings about potential treatments. Only around one ...
Struggling with lower back pain with no relief? Dr. Jonathan Stevenson from Strive Integrative Health highlights the Back-On-Trac spinal traction treatment.
Lower back and hip pain is common. According to the World Health Organization (WHO), an estimated 619 million people live with lower back pain and it’s the leading cause of disability worldwide. But ...
Treatment for lower back and hip pain from arthritis typically begins with medications and physical therapy. When conservative treatments aren’t enough, surgery and certain complementary therapies may ...
Older adults with chronic low back pain (CLBP) had less pain and improved physical function using acupuncture compared to standard treatments, a National Institutes of Health (NIH)-funded clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results